425 related articles for article (PubMed ID: 18353309)
21. Modification of the potent peptide FK888 with unusual aminoacids: effects on activity on neurokinin receptors.
Caliendo G; Greco G; Grieco P; Perissutti E; Santagada V; Calignano A; Mancuso F; Novellino E
Farmaco; 1996 Mar; 51(3):197-201. PubMed ID: 8688142
[TBL] [Abstract][Full Text] [Related]
22. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
23. Electrophysiological effects of tachykinins and capsaicin on guinea-pig bronchial parasympathetic ganglion neurones.
Myers AC; Undem BJ
J Physiol; 1993 Oct; 470():665-79. PubMed ID: 7508508
[TBL] [Abstract][Full Text] [Related]
24. Involvement of neurokinin receptors in the control of pulsatile luteinizing hormone secretion in rats.
Noritake K; Matsuoka T; Ohsawa T; Shimomura K; Sanbuissho A; Uenoyama Y; Maeda K; Tsukamura H
J Reprod Dev; 2011 Jun; 57(3):409-15. PubMed ID: 21358144
[TBL] [Abstract][Full Text] [Related]
25. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]-4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin 1 receptor: II. Neurochemical and behavioral characterization.
Steinberg R; Alonso R; Rouquier L; Desvignes C; Michaud JC; Cudennec A; Jung M; Simiand J; Griebel G; Emonds-Alt X; Le Fur G; Soubrié P
J Pharmacol Exp Ther; 2002 Dec; 303(3):1180-8. PubMed ID: 12438542
[TBL] [Abstract][Full Text] [Related]
26. Structural optimization affording 2-(R)-(1-(R)-3, 5-bis(trifluoromethyl)phenylethoxy)-3-(S)-(4-fluoro)phenyl-4- (3-oxo-1,2,4-triazol-5-yl)methylmorpholine, a potent, orally active, long-acting morpholine acetal human NK-1 receptor antagonist.
Hale JJ; Mills SG; MacCoss M; Finke PE; Cascieri MA; Sadowski S; Ber E; Chicchi GG; Kurtz M; Metzger J; Eiermann G; Tsou NN; Tattersall FD; Rupniak NM; Williams AR; Rycroft W; Hargreaves R; MacIntyre DE
J Med Chem; 1998 Nov; 41(23):4607-14. PubMed ID: 9804700
[TBL] [Abstract][Full Text] [Related]
27. Neurokinin receptor modulation of respiratory activity in the rabbit.
Bongianni F; Mutolo D; Cinelli E; Pantaleo T
Eur J Neurosci; 2008 Jun; 27(12):3233-43. PubMed ID: 18554294
[TBL] [Abstract][Full Text] [Related]
28. Effect of MDL 105,212, a nonpeptide NK-1/NK-2 receptor antagonist in an allergic guinea pig model.
Kudlacz EM; Knippenberg RW; Logan DE; Burkholder TP
J Pharmacol Exp Ther; 1996 Nov; 279(2):732-9. PubMed ID: 8930178
[TBL] [Abstract][Full Text] [Related]
29. The triple neurokinin-receptor antagonist CS-003 inhibits neurokinin A-induced bronchoconstriction in patients with asthma.
Schelfhout V; Louis R; Lenz W; Heyrman R; Pauwels R; Joos G
Pulm Pharmacol Ther; 2006; 19(6):413-8. PubMed ID: 16364669
[TBL] [Abstract][Full Text] [Related]
30. Pharmacological profile of (2R-trans)-4-[1-[3,5-bis(trifluoromethyl)benzoyl]-2-(phenylmethyl)-4-piperidinyl]-N-(2,6-dimethylphenyl)-1-acetamide (S)-Hydroxybutanedioate (R116301), an orally and centrally active neurokinin-1 receptor antagonist.
Megens AA; Ashton D; Vermeire JC; Vermote PC; Hens KA; Hillen LC; Fransen JF; Mahieu M; Heylen L; Leysen JE; Jurzak MR; Janssens F
J Pharmacol Exp Ther; 2002 Aug; 302(2):696-709. PubMed ID: 12130734
[TBL] [Abstract][Full Text] [Related]
31. Plasma extravasation induced by neurokinins in conscious rats: receptor characterization with agonists and antagonists.
Nicolau M; Sirois MG; Bui M; Plante GE; Sirois P; Regoli D
Can J Physiol Pharmacol; 1993; 71(3-4):217-21. PubMed ID: 7691388
[TBL] [Abstract][Full Text] [Related]
32. Effects of tachykinin receptor antagonists, FK224 and FK888, in a guinea-pig model of nasal allergy.
Katahashi T; Konno A
Rhinology; 1997 Jun; 35(2):63-6. PubMed ID: 9299653
[TBL] [Abstract][Full Text] [Related]
33. Effect of YM-44781, YM-44778 and YM-49598, novel tachykinin antagonists, in a drug-induced bladder contraction model.
Choppin A; Groke G; Bringas A; Stepan G; Dillon MP
Pharmacology; 2002 May; 65(2):96-102. PubMed ID: 11937780
[TBL] [Abstract][Full Text] [Related]
34. Inhibition by capsazepine of resiniferatoxin- and capsaicin-induced contractions of guinea pig trachea.
Ellis JL; Undem BJ
J Pharmacol Exp Ther; 1994 Jan; 268(1):85-9. PubMed ID: 8301598
[TBL] [Abstract][Full Text] [Related]
35. Nonpeptide tachykinin receptor antagonists. III. SB 235375, a low central nervous system-penetrant, potent and selective neurokinin-3 receptor antagonist, inhibits citric acid-induced cough and airways hyper-reactivity in guinea pigs.
Hay DW; Giardina GA; Griswold DE; Underwood DC; Kotzer CJ; Bush B; Potts W; Sandhu P; Lundberg D; Foley JJ; Schmidt DB; Martin LD; Kilian D; Legos JJ; Barone FC; Luttmann MA; Grugni M; Raveglia LF; Sarau HM
J Pharmacol Exp Ther; 2002 Jan; 300(1):314-23. PubMed ID: 11752131
[TBL] [Abstract][Full Text] [Related]
36. Characterization of species-related differences in the pharmacology of tachykinin NK receptors 1, 2 and 3.
Leffler A; Ahlstedt I; Engberg S; Svensson A; Billger M; Oberg L; Bjursell MK; Lindström E; von Mentzer B
Biochem Pharmacol; 2009 May; 77(9):1522-30. PubMed ID: 19426690
[TBL] [Abstract][Full Text] [Related]
37. Potent and highly selective neurokinin antagonists.
Ward P; Ewan GB; Jordan CC; Ireland SJ; Hagan RM; Brown JR
J Med Chem; 1990 Jul; 33(7):1848-51. PubMed ID: 1694545
[No Abstract] [Full Text] [Related]
38. Tachykinin receptor subtypes in the isolated guinea pig heart and their role in mediating responses to neurokinin A.
Chang Y; Hoover DB; Hancock JC; Smith FM
J Pharmacol Exp Ther; 2000 Jul; 294(1):147-54. PubMed ID: 10871306
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and in vitro activities of highly potent and selective tripeptide antagonists of the neurokinin NK-1 receptor.
Caliendo G; Greco G; Grieco P; Perissutti E; Santagada V; Calignano A; Mancuso F; Novellino E
Farmaco; 1995 Nov; 50(11):755-9. PubMed ID: 8593172
[TBL] [Abstract][Full Text] [Related]
40. Vasopressin release from the rat hypothalamo-neurohypophysial system: effects of tachykinin NK-1 and NK-2 receptors agonists and antagonists.
Juszczak M
Neuro Endocrinol Lett; 2005 Aug; 26(4):367-72. PubMed ID: 16136007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
